| Literature DB >> 29506958 |
Jian Yang1, Marta Barniol-Xicota1, Minh T N Nguyen2, Anezka Ticha3, Kvido Strisovsky3, Steven H L Verhelst4.
Abstract
Rhomboid proteases form one of the most widespread intramembrane protease families. They have been implicated in variety of human diseases. The currently reported rhomboid inhibitors display some selectivity, but their construction involves multistep synthesis protocols. Here, we report benzoxazin-4-ones as novel inhibitors of rhomboid proteases with a covalent, but slow reversible inhibition mechanism. Benzoxazin-4-ones can be synthesized from anthranilic acid derivatives in a one-step synthesis, making them easily accessible. We demonstrate that an alkoxy substituent at the 2-position is crucial for potency and results in low micromolar inhibitors of rhomboid proteases. Hence, we expect that these compounds will allow rapid synthesis and optimization of inhibitors of rhomboids from different organisms.Entities:
Keywords: Activity-based protein profiling; Benzoxazinones; Inhibitors; Intramembrane proteases; Rhomboid proteases
Mesh:
Substances:
Year: 2017 PMID: 29506958 DOI: 10.1016/j.bmcl.2017.12.056
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823